Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) Net Margin (2020 - 2025)

KORU Medical Systems has reported Net Margin over the past 11 years, most recently at 4.47% for Q4 2025.

  • Quarterly results put Net Margin at 4.47% for Q4 2025, up 1316.0% from a year ago — trailing twelve months through Dec 2025 was 6.41% (up 1161.0% YoY), and the annual figure for FY2025 was 6.41%, up 1162.0%.
  • Net Margin for Q4 2025 was 4.47% at KORU Medical Systems, up from 7.48% in the prior quarter.
  • Over the last five years, Net Margin for KRMD hit a ceiling of 2.03% in Q2 2025 and a floor of 103.9% in Q4 2023.
  • Median Net Margin over the past 5 years was 19.43% (2023), compared with a mean of 24.84%.
  • Biggest five-year swings in Net Margin: crashed -7698bps in 2023 and later surged 8627bps in 2024.
  • KORU Medical Systems' Net Margin stood at 16.46% in 2021, then crashed by -64bps to 26.91% in 2022, then plummeted by -286bps to 103.9% in 2023, then soared by 83bps to 17.63% in 2024, then soared by 75bps to 4.47% in 2025.
  • The last three reported values for Net Margin were 4.47% (Q4 2025), 7.48% (Q3 2025), and 2.03% (Q2 2025) per Business Quant data.